Brenda Iveson, 92, is the first patient in the UK to receive a pioneering robotic therapy for liver cancer, according to multiple reports. She was diagnosed with liver cancer in late 2025 after doctors identified a six-centimetre tumour in her liver. Initially, clinicians told her that conventional treatments were unlikely to work and that the tumour was effectively “inoperable” or otherwise “untreatable” using standard approaches.
The accounts say her care team then arranged access to the UK’s first use of the robotic treatment, described as a novel therapy aimed at tackling cancers that are difficult to treat with existing methods. Reporting focuses on her age and the severity of her tumour and notes that the treatment is being presented as a new option for patients whose conditions are deemed unsuitable for conventional therapies.
The coverage does not provide detailed outcome data in the supplied excerpts, but it consistently frames the case as a UK-first and highlights the change from an initial prognosis of limited options to receiving the robotic intervention.
